fda shortage tirzepatide update Compounded Semaglutide & 2025: Safe Use Guide tirzepatide fda shortage 🚨 FDA

The new indication follows positive results in a phase III trial that found children and adolescents living with type 1 diabetes (T1D) achieved comparable reduction in average blood sugar (HbA1c) and similar risk of low blood sugar events with Toujeo when compared to insulin glargine 100 units/mL (Gla-100)

Restless legs syndrome is associated with long-COVID in women

Snell, F

Neuroprotective and Cardiovascular Research : There is growing interest in the neuroprotective and cardiovascular effects of GLP-1 T , with studies examining its potential to reduce the risk of heart disease and neurological disorders

No receptor competition, no metabolic interference, no absorption conflicts, and manageable physiological cross-talk

doi: 10.1097/MCO.0000000000000468 103 RyanP